Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study

NCT03292666 · clinicaltrials.gov ↗

COMPLETED

Status

39603

Enrollment

OTHER

Sponsor class

Conditions

Venous Thromboembolism
Anticoagulants and Bleeding Disorders

Interventions

DRUG: Oral Anticoagulant

Sponsor

University of California, San Francisco

Collaborators

[object Object]
[object Object]